Publications by authors named "Yingqian Jiang"

Biocatalysis is an effective approach for producing chiral drug intermediates that are often difficult to synthesize using traditional chemical methods. A time-efficient strategy is required to accelerate the directed evolution process to achieve the desired enzyme function. In this research, we evaluated machine learning-assisted directed evolution as a potential approach for enzyme engineering, using a moderately diastereoselective ketoreductase library as a model system.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer metastasis and recurrence present significant challenges in treating aggressive cancers, necessitating effective chemotherapy, especially after surgery.
  • The development of doxorubicin-carried albumin nanocages (Dox-AlbCages) offers a targeted approach to enhance drug delivery and reduce side effects by utilizing serum albumin's transport properties.
  • Dox-AlbCages demonstrated effectiveness in inhibiting tumor growth and metastasis in breast cancer models while showing fewer side effects compared to traditional doxorubicin treatments.
View Article and Find Full Text PDF

Chiral β-hydroxyphosphonates are essential building blocks for organophosphorus compounds. However, the asymmetric synthesis of these units remains a significant challenge. Herein, we describe a one-pot chemoenzymatic cascade process to access chiral β-hydroxyphosphonates, which combines photo-oxidative chemical reactions and bioreductions.

View Article and Find Full Text PDF
Article Synopsis
  • The study conducted a bibliometric analysis of 98,980 articles on antitumor nanocarriers published between 2013 and 2023 to explore trends in cancer nanomedicine.
  • China emerged as the leading country in this research area, with the Chinese Academy of Sciences being the most prolific organization, while major keywords identified included "nanoparticles," "drug delivery," and "cancer immunotherapy."
  • The research unveiled six keyword clusters, highlighting significant topics and recent trends, providing valuable insights and directions for future studies in the field of cancer nanomedicine.
View Article and Find Full Text PDF

Two new polysaccharides, AZP-1a and AZP-1d, with molecular weights of 3.41 × 10 and 4568 Da, respectively, were extracted from Anoectochilus zhejiangensis and purified by column chromatography. Their structural characteristics were systematically explored and results indicated AZP-1a and AZP-1d shared a similar backbone consisted of→4)-Galp-(1→, →4)-Glcp-(1→, and →4,6)-Glcp-(1→, with a different terminal residue of Manp-(1 → and Glcp-(1→, respectively.

View Article and Find Full Text PDF